An innovative new system that has the potential to revolutionise hearing tests globally has received financial backing from Scottish business angel investment syndicate, Archangels.  Edinburgh-based Hearing Diagnostics Limited has received £715,000 of investment which will enable its hearing test system to undergo trials with universities and hearing aid retailers in the UK with a view to full market launch in 2021.

The £5m investment, made on behalf of the Baronsmead VCTs, is in addition to further investment from existing shareholders and will support the expansion of eConsult Health into the secondary care market.

Beyond maintaining its position as the leading digital triage services in GP surgeries, eConsult Health will continue the rollout of its Urgent and Emergency Care triage solution, eTriage, and outpatient referral software, eSpecialist.

Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy (CGT) manufacturing, today announced the successful close of a $30 million Series A financing round, bringing the company’s total funding to date to $41 million. The new funding will be used to help bring Ori’s innovative manufacturing platform to the market. The Ori platform delivers scalable solutions to flexibly address the critical clinical and commercial manufacturing needs of CGT developers.

British digital health start-up Clin-e-cal has raised over £130,000 on leading crowdfunding platform Crowdcube to fund the commercialisation and scale-up of its smart inhaler monitoring technology. Clin-e-cal’s smartphone apps use unique SoundResponse® technology, which analyses sound signals asscociated with the inhaler device. The apps then use these sound signals to provide real-time visual feedback to users on their inhalation technique, as well as tracking their adherence.

London startup, Jelly Drops, has launched in the UK to help boost the water intake of the elderly and 850,000 Britons living with dementia that have been amongst the hardest hit by the pandemic. Dehydration is especially common amongst the elderly, especially those  with dementia, as they often forget to drink. In fact,  37% of older people admitted into hospitals are acutely dehydrated.  

Immune Regulation Limited, a US and UK based clinical stage biotechnology company, has closed a Series B funding round led by Boston based Morningside Ventures, alongside existing shareholders including London based 24Haymarket.

Piper has invested £11.5m investment into Wattbike, the world's first smart indoor bike brand, joining the impressive team, led by CEO Rich Baker, on their mission to make Wattbike a global brand legend. The team will also be joined by non-executive chairman Gordon Baird, former chairman of sports footwear brand Inov-8 and swimwear brand Zoggs.

Award-winning health tech company DrDoctor has raised £3,000,000 Series A Round investment from venture capital firms Ananda Impact Ventures and 24Haymarket. The money will be used to hire across the business and add new functionality to DrDoctor’s patient communication platform, which transforms the way hospitals communicate with their patients, ensuring fewer missed appointments across the NHS, lower administrative costs for hospitals and clinics, and more timely care for patients.

HomeDoctor, a Warsaw and Amsterdam-based digital healthcare provider has announced a €3,7m Series A funding round led by Cogito Capital Partners with participation from the Company’s founders. HomeDoctor, founded in 2016, is a leader in the Polish market in providing online medical consultations and delivery of healthcare services to patients’ homes. The Company is operating as a b2b2c and a b2c medical services platform that enables delivery of both, online and phone consultations (telemedicine channel) and booking a doctor appointment (home visit).

Panthera Biopartners has completed a Series A funding round with Gresham House Ventures as a major investor. The capital raised will enable Panthera to further build out its network of clinical trial sites across the UK and overseas and increase its team of clinical trial experts in serving both pharma and patients.

Panthera Biopartners has completed a Series A funding round with Gresham House Ventures as a major investor. The capital raised will enable Panthera to further build out its network of clinical trial sites across the UK and overseas and increase its team of clinical trial experts in serving both pharma and patients.

Dublin start-up FoodMarble has raised €1.2M in a funding round which included HBAN business angels from the MedTech syndicate who invested alongside Enterprise Ireland, SOSV and Delta Partners. The investment will support the company's ongoing research and development, along with expansion into the US and Canada.